Exponent (NASDAQ:EXPO) delivered a solid start to fiscal 2026, reporting first-quarter results that topped analyst expectations on both revenue and earnings. The engineering and scientific consulting firm posted double-digit growth in revenues and net income, driven by demand for its specialized expertise across a range of industries, from consumer electronics to energy.
Revenue and Earnings Beat Estimates
For the quarter ended April 3, 2026, Exponent reported revenues before reimbursements of $151.8 million, a 10% increase year-over-year. Total revenues, which include reimbursements, came in at $166.3 million, up 14% from the prior year. This top-line performance surpassed analyst estimates, which had forecast revenues before reimbursements of approximately $156.1 million.
On the bottom line, the company reported net income of $29.6 million, or $0.59 per diluted share. This compares favorably to the $26.7 million, or $0.52 per diluted share, reported in the same quarter last year and edged past the consensus estimate of $0.58 per share.
- Revenues Before Reimbursements: $151.8 million (vs. $137.4 million in Q1 2025)
- Net Income: $29.6 million (vs. $26.7 million in Q1 2025)
- Diluted EPS: $0.59 (vs. $0.52 in Q1 2025)
- Analyst Estimates: Revenue of ~$156.1M; EPS of $0.58
Key Drivers and Business Segments
Management attributed the strong quarter to growth in both proactive and reactive engagements. The company's engineering and other scientific segment, which makes up 85% of revenues before reimbursements, saw 12% growth. This was fueled by user research studies for consumer electronics clients integrating AI into devices, risk management work for utilities evaluating asset performance under extreme weather, and increased dispute-related work in construction, energy, and life sciences.
The environmental and health segment, representing 15% of revenues, grew 2%, driven by regulatory consulting in the chemical industry.
"We delivered double-digit growth in revenues and earnings during the first quarter, reflecting the strength of our multidisciplinary portfolio and increased demand for our specialized expertise across industries," stated Dr. Catherine Corrigan, President and CEO.
Outlook and Capital Returns
Looking ahead, Exponent provided guidance for the second quarter and maintained its outlook for the full fiscal year. The company expects revenues before reimbursements to grow in the high-single digits for both Q2 and the full year. It also forecast EBITDA margins of 27.0% to 27.8% for the second quarter and 27.6% to 28.1% for the full year.
This guidance aligns with current analyst estimates for the full year, which project revenues before reimbursements of roughly $230.5 million for Q2 and $605.2 million for 2026.
In addition to the operational update, Exponent announced it will pay a quarterly cash dividend of $0.31 on June 18, 2026. The company also increased its stock repurchase authorization by $50 million, adding to the $17.7 million already available. During the quarter, Exponent repurchased $78.8 million of its common stock, signaling confidence in its financial position and future prospects.
Market Reaction
Despite the earnings beat and positive outlook, the stock’s after-market performance has been muted, showing no change from its closing price. Over the past month, the stock is up roughly 2.9%, but it has pulled back about 1.8% over the last two weeks. The tepid immediate reaction may reflect that the results, while solid, were largely in line with or only modestly above expectations, with the top line actually slightly missing the consensus revenue estimate. Investors may be taking a wait-and-see approach as they assess the sustainability of the high-single-digit growth trajectory in a shifting economic landscape.
Important Links for Investors
For a deeper dive into Exponent's historical earnings performance and future projections, investors can review the detailed data and analyst estimates.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with a financial professional before making any investment decisions.